Sarepta Therapeutics Inc (NASDAQ:SRPT)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Recs

0
Player Avatar RyanCoke (99.70) Submitted: 10/3/2012 10:43:41 AM : Underperform Start Price: $40.80 SRPT Score: +32.68

Up 164% today? I have to think there's going to be SOME profit taking.

Featured Broker Partners


Advertisement